This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Carolyn Mazzitelli, PhD
Executive Director at Ionis Pharmaceuticals
Speaker

Profile

Carolyn is an Executive Director in the Analytical Development & Quality Control department at Ionis Pharmaceuticals where she leads a team responsible for the analytical activities of oligonucleotides in all phases of development. Her expertise includes method development, validation, stability testing, establishing specifications, authoring regulatory submissions, and supporting commercial product launches. Prior to joining Ionis, she worked at Dart NeuroScience, Gilead Sciences, and Vertex Pharmaceuticals where she was responsible for the analytical development of small molecule drug substances and drug products. She earned a B.S. in Chemistry from the University of North Carolina at Chapel Hill and Ph.D. in Chemistry from the University of Texas at Austin.

Agenda Sessions

  • Strategies for Demonstrating Comparability of Oligonucleotide Therapeutics Following Manufacturing Changes

    9:40am